Immuron Announces Clinical Trial Update
Immuron Announces Clinical Trial Update GlobeNewswire October 31, 2025 IMM-529 IND: currently under review, FDA request for Information – minor updates to clinical protocol completed and submitted Travelan(R) P2TD (n=851) Uniformed Services University study topline data delayed to the end of November due to U.S government shutdown MELBOURNE, Australia, Oct. 31, 2025 (GLOBE NEWSWIRE) — […]